General practitioners' experiences, attitudes, and opinions regarding the pneumococcal vaccination for adults: a qualitative study.

Nina Badertscher, Seraina Morell, Thomas Rosemann, Ryan Tandjung
Author Information
  1. Nina Badertscher: Institute of General Practice and Health Services Research, University of Zurich, Zurich, Switzerland.

Abstract

INTRODUCTION: Diseases caused by Streptococcus pneumoniae generate substantial morbidity and mortality. Despite official recommendations to vaccinate everyone over the age of 64, the estimated vaccination rate for this target population is around 2%. In Switzerland, pneumococcal vaccinations are for the most part provided by general practitioners (GPs); in addition, a small number of patients get vaccinated during a hospital stay. We wanted to investigate GPs' attitudes and opinions about the pneumococcal vaccination in primary care and why it is so rarely provided.
METHODS: For this qualitative study, we conducted semistructured interviews with 20 GPs. Transcriptions of all interviews were analyzed following the technique of qualitative content analysis, supported by the ATLAS.ti(©) software.
RESULTS: Most GPs reported that they know pneumococcal vaccination is recommended for several risk groups and elderly patients. As to reasons for the low vaccination rate, GPs mentioned the pneumococcal vaccination had little priority in daily practice, especially in comparison with the importance of other vaccinations, namely influenza. This low level of priority was supported by the fact that the GPs rarely ever experienced a case of a severe pneumococcal disease in their daily work. Furthermore, perceived insufficient evidence resulting from existing epidemiologic data and clinical trials enhanced the little attention given to the pneumococcal vaccination.
CONCLUSION: We found the generally low level of priority given within a consultation, the missing awareness of this subject in daily practice, and the perception of epidemiologic and scientific data as insufficient, as the reasons for the low rate in pneumococcal vaccinations. Efforts to increase the epidemiologic data on the pneumococcal vaccination should be taken. To increase the vaccination rate, it would be necessary to raise the awareness and priority of the pneumococcal vaccination; a feasible way could be the combination of the seasonal flu vaccination campaign with a campaign for pneumococcal vaccination.

Keywords

References

  1. Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):763-9 [PMID: 19507170]
  2. BMC Fam Pract. 2000;1:1 [PMID: 11038265]
  3. Psychother Psychosom Med Psychol. 2011 Jun;61(6):e34-5 [PMID: 21656437]
  4. Arch Intern Med. 1994 Dec 12-26;154(23):2666-77 [PMID: 7993150]
  5. Vaccine. 2001 Sep 14;19(32):4760-7 [PMID: 11535327]
  6. Aust N Z J Public Health. 2007 Dec;31(6):558-61 [PMID: 18081577]
  7. Arch Intern Med. 2011 Sep 26;171(17):1552-8 [PMID: 21949163]
  8. J Eval Clin Pract. 2008 Apr;14(2):185-90 [PMID: 18093108]
  9. Vaccine. 2009 Jun 8;27(28):3775-9 [PMID: 19464561]
  10. Cochrane Database Syst Rev. 2003;(4):CD000422 [PMID: 14583920]
  11. Vaccine. 2008 Oct 16;26(44):5633-40 [PMID: 18706955]
  12. Vaccine. 2008 Jan 10;26(2):234-40 [PMID: 18054818]
  13. Swiss Med Wkly. 2010 Sep 13;140:w13088 [PMID: 20853193]
  14. CMAJ. 2009 Jan 6;180(1):48-58 [PMID: 19124790]
  15. BMJ. 2008 Aug 07;337:a288 [PMID: 18687727]
  16. BMC Fam Pract. 2012 Mar 20;13:22 [PMID: 22433118]
  17. Eur J Epidemiol. 2004;19(4):353-63 [PMID: 15180106]
  18. Swiss Med Wkly. 2005 Apr 2;135(13-14):192-9 [PMID: 15909236]
  19. Can Fam Physician. 1999 Oct;45:2381-93 [PMID: 10540698]
  20. Cardiovasc Diabetol. 2010 Jun 15;9:23 [PMID: 20550650]
  21. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000422 [PMID: 18253977]
  22. Vaccine. 2002 Jan 31;20(9-10):1383-92 [PMID: 11818157]
  23. Vaccine. 2003 Mar 28;21(13-14):1510-7 [PMID: 12615448]
  24. Vaccine. 2001 Sep 14;19(32):4780-90 [PMID: 11535330]

Word Cloud

Created with Highcharts 10.0.0vaccinationpneumococcalGPsratelowpriorityvaccinationsqualitativedailyepidemiologicdataStreptococcuspneumoniaeprovidedpatientsattitudesopinionsprimarycarerarelystudyinterviewssupportedreasonslittlepracticelevelinsufficientgivenawarenessincreasecampaignINTRODUCTION:DiseasescausedgeneratesubstantialmorbiditymortalityDespiteofficialrecommendationsvaccinateeveryoneage64estimatedtargetpopulationaround2%SwitzerlandpartgeneralpractitionersadditionsmallnumbergetvaccinatedhospitalstaywantedinvestigateGPs'METHODS:conductedsemistructured20TranscriptionsanalyzedfollowingtechniquecontentanalysisATLASti©softwareRESULTS:reportedknowrecommendedseveralriskgroupselderlymentionedespeciallycomparisonimportancenamelyinfluenzafacteverexperiencedcaseseverediseaseworkFurthermoreperceivedevidenceresultingexistingclinicaltrialsenhancedattentionCONCLUSION:foundgenerallywithinconsultationmissingsubjectperceptionscientificEffortstakennecessaryraisefeasiblewaycombinationseasonalfluGeneralpractitioners'experiencesregardingadults:Swissbarriersfacilitatorsprevention

Similar Articles

Cited By